The Medicine Maker - Bioavailability By Design

Summary: Few oral biologics have made it to market, and though the challenges are well known, the benefits are huge and the task is not impossible. This article, originally published in "The Medicine Maker", addresses bioavailability challenges faced in biologic development with a focus on the oral delivery. Stephen Tindal, Director, Science and Technology at Catalent Pharma discusses the technology platform designed to help overcome bioavailability challenges for early-stage large molecules.

Click here to download the article.